222 related articles for article (PubMed ID: 6305312)
1. A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice.
Gordon Y; Gilden DH; Shtram Y; Asher Y; Tabor E; Wellish M; Devlin M; Snipper D; Hadar J; Becker Y
Arch Virol; 1983; 76(1):39-49. PubMed ID: 6305312
[TBL] [Abstract][Full Text] [Related]
2. Neurovirulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression.
Ben-Hur T; Hadar J; Shtram Y; Gilden DH; Becker Y
Arch Virol; 1983; 78(3-4):303-8. PubMed ID: 6318700
[TBL] [Abstract][Full Text] [Related]
3. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation.
Tenser RB; Edris WA
J Virol; 1987 Jul; 61(7):2171-4. PubMed ID: 3035217
[TBL] [Abstract][Full Text] [Related]
4. Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant.
Wilcox CL; Crnic LS; Pizer LI
Virology; 1992 Mar; 187(1):348-52. PubMed ID: 1310559
[TBL] [Abstract][Full Text] [Related]
5. Acute and latent infection by thymidine kinase mutants of herpes simplex virus type 2.
Tenser RB; Jones JC; Ressel SJ
J Infect Dis; 1985 Mar; 151(3):548-50. PubMed ID: 2982968
[No Abstract] [Full Text] [Related]
6. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
Coen DM; Irmiere AF; Jacobson JG; Kerns KM
Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression promotes ocular virus replication and CNS neurovirulence following corneal inoculation with an avirulent herpes simplex type 1 thymidine kinase negative mutant.
Gordon YJ; Rao H; Arullo-Cruz T
Curr Eye Res; 1984 Apr; 3(4):651-7. PubMed ID: 6325093
[TBL] [Abstract][Full Text] [Related]
8. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985
[TBL] [Abstract][Full Text] [Related]
9. Co-cultivation versus blot hybridization for the detection of trigeminal ganglionic latency following corneal inoculation with HSV-1 strains of varying TK expression and pathogenicity.
Gordon YJ; Rock DL
Curr Eye Res; 1984 Sep; 3(9):1097-100. PubMed ID: 6092001
[TBL] [Abstract][Full Text] [Related]
10. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus.
Tenser RB; Miller RL; Rapp F
Science; 1979 Aug; 205(4409):915-7. PubMed ID: 224454
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion.
Tenser RB; Dunstan ME
Virology; 1979 Dec; 99(2):417-22. PubMed ID: 229629
[No Abstract] [Full Text] [Related]
12. Detection of latent thymidine kinase-deficient herpes simplex virus in trigeminal ganglia of mice using the polymerase chain reaction.
Friedrich A; Kleim JP; Schneweis KE
Arch Virol; 1990; 113(1-2):107-13. PubMed ID: 2167055
[TBL] [Abstract][Full Text] [Related]
13. A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia.
Steiner I; Spivack JG; Deshmane SL; Ace CI; Preston CM; Fraser NW
J Virol; 1990 Apr; 64(4):1630-8. PubMed ID: 2157048
[TBL] [Abstract][Full Text] [Related]
14. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice.
Yamada Y; Kimura H; Morishima T; Daikoku T; Maeno K; Nishiyama Y
J Infect Dis; 1991 Dec; 164(6):1091-7. PubMed ID: 1659596
[TBL] [Abstract][Full Text] [Related]
15. The role of herpes simplex thymidine kinase expression in neurovirulence and latency in newborn vs. adult mice.
Hay KA; Gaydos A; Tenser RB
J Neuroimmunol; 1995 Aug; 61(1):41-52. PubMed ID: 7560011
[TBL] [Abstract][Full Text] [Related]
16. Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.
Huang CY; Yao HW; Wang LC; Shen FH; Hsu SM; Chen SH
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974554
[TBL] [Abstract][Full Text] [Related]
17. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.
Efstathiou S; Kemp S; Darby G; Minson AC
J Gen Virol; 1989 Apr; 70 ( Pt 4)():869-79. PubMed ID: 2543763
[TBL] [Abstract][Full Text] [Related]
18. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
Liu WG; Chen ZJ; Song JZ; Ma ZX
Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
[TBL] [Abstract][Full Text] [Related]
19. Neuronal control of herpes simplex virus latency.
Tenser RB; Edris WA; Hay KA
Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo.
Idowu AD; Fraser-Smith EB; Poffenberger KL; Herman RC
Antiviral Res; 1992 Feb; 17(2):145-56. PubMed ID: 1313220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
